Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Morocco Launches First Cannabis-Based Epilepsy Drug
Details : Cannabidiol Pharma 5 is a CB1 negative allosteric modulator, small molecule drug candidate, which is indicated for the treatment of epilepsy.
Product Name : Cannabidiol Pharma 5
Product Type : Controlled Substance
Upfront Cash : Inapplicable
December 20, 2024
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable